ASweetLife Team, Author at ASweetLife

Check Your Vitamin D Level

Vitamin D deficiency can contribute to retinopathy in young people with type 1 diabetes, according to a new study published in Diabetes Care. If you haven't checked your vitamin D level recently, ask your doctor to check next time you go in for an HbA1c test.

Researchers Discover Mechanism That Converts Certain Cells into Insulin Producing Beta Cells

Researchers from UCLA's Larry L. Hillblom Islet Research Center have discovered the underlying mechanism that could convert other cell types into pancreatic beta cells. It had long been assumed that the identity of cells was "locked" into place and that they could not be switched into other cell types...

Vitamin D Deficiency May Contribute to Diabetic Retinopathy in Children and Adolescents

A new study has found vitamin D deficiency to be associated with retinopathy in children and adolescents with type 1 diabetes. The study, published online ahead of print in Diabetes Care, set out to examine the hypothesis that vitamin D deficiency...

Diabetic Pilot Reaches the North Pole

Douglas Cairns, a former British Royal Air Force jet pilot who has type 1 diabetes, has completed his Diabetes Polar Flight expedition. He reached the geographic North Pole, as planned, just after 5pm Alaska time (0100 GMT) and said he felt “great. Fantastic – it’s really good fun.”...

Artificial Pancreas Provides Better Nighttime Blood Sugar Control Than the Pump

The artificial pancreas is better at controlling night time blood sugar levels than conventional pump therapy according to two knew studies carried out at the Wellcome Trust clinical research facility at Addenbrooke’s Hospital in England....

Bydureon Receives Positive Opinion From The European Medicines Agency

Eli Lilly and Company, Amylin Pharmaceuticals and Alkermes announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending approval of Bydureon for injection in the European Union for the treatment of type 2 diabetes in combination with...

Victoza More Effective Than Competitors New Study Shows

A new meta study presented by Novo Nordisk at the 20th Annual Meeting and Clinical Congress of the American Association of Clinical Endocrinologists (AACE) shows that regardless of baseline A1C, once-daily Victoza (liraglutide [rDNA origin] injection) 1.8 mg consistently helped more patients achieve blood sugar control than...

IDF Launches International Charter of Rights and Responsibilities of People with Diabetes

The International Diabetes Federation (IDF) today launched the first ever Charter setting out the fundamental rights of more than 300 million people living with diabetes...

Sanofi-aventis Announces Positive Results for Lixisenatide

Sanofi-aventis announced today that lixisenatide, a once-daily GLP-1 receptor agonist under development for people with type 2 diabetes, achieved its primary efficacy objective of significant HbA1c reduction and improved glycemic control from...

Medtronic Launches New Improved CGM Sensor

Medtronic has launched the Enlite Sensor, the newest and most advanced glucose sensor for continuous glucose monitoring (CGM), in more than 35 countries outside of the United States. The new Enlite Sensor combines greater comfort with improved glucose sensor performance in both overall accuracy and detection of hypoglycemia...